Gel Coat Biomaterials, inc.

Gel Coat Biomaterials, Inc. is a biotechnology startup founded in 2024 based on hydrogel technology developed by Professor Madoka Takai of the University of Tokyo. The company specializes in a proprietary biocompatible hydrogel, known as Gel Coat, which utilizes uniquely structured zwitterionic polymers to encapsulate and stabilize biomolecules such as enzymes, aptamers, nucleic acids, and cells. By surrounding these materials with a protective hydration layer, the technology enables long-term stabilization, immobilization, and thermal protection, effectively overcoming the inherent instability that often limits the application and duration of biological materials in various environments.

This technology addresses critical challenges in the bioindustry by allowing for more efficient use of biological materials. The company's solutions are targeted at applications including green chemistry to enhance sustainability, the long-term preservation of stem cells and organs, and the development of medical devices capable of generating power within the body for deep-tissue disease treatment. Supported by Series A financing from investors such as WASEDA University Ventures, the company aims to leverage its expertise in polymer chemistry and device technology to expand the utility of biomaterials across medical and industrial sectors.